Form 4: UNH CEO Hemsley Reports Routine Stock Unit Dividend
Insider Transaction Report
UnitedHealth Group CEO Stephen J. Hemsley reported the acquisition of 50 shares of common stock through dividend equivalents on vested deferred stock units.
Summary
- Stephen J. Hemsley, CEO and Director of UnitedHealth Group (UNH), acquired 50 shares of UNH common stock on September 23, 2025.
- This acquisition represents dividend equivalents paid on vested deferred stock units, which were immediately vested and subject to the same terms as the underlying units.
- Following this transaction, Hemsley directly owns 427,895.942 shares of common stock.
- Indirect beneficial ownership includes 349.7439 shares via a 401(k) and 681,875 shares via trusts.
- Internal transfers of 58,795 shares from trusts to direct holdings and 5,555 shares from direct holdings to trusts occurred on August 14, 2025, which were exempt from reporting under Rule 16a-13.
Sentiment
Score: 6
Explanation: The filing reports a routine acquisition of shares through dividend equivalents, which is a positive but expected outcome of existing equity compensation and does not indicate a significant change in company prospects.
Positives
- CEO Stephen J. Hemsley's beneficial ownership of UnitedHealth Group common stock increased by 50 shares.
- The acquisition was due to dividend equivalents on vested deferred stock units, indicating ongoing benefits from existing equity compensation arrangements.
Stakeholder Impact
- Shareholders benefit from transparency regarding executive stock ownership and compensation.
- The increase in shares held by the CEO, even if minor and routine, aligns management's interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 08/14/2025 | Internal transfers of shares between direct holdings and trusts, exempt from reporting under Rule 16a-13. |
| 09/23/2025 | Date of transaction: acquisition of 50 common stock shares as dividend equivalents. |
| 09/25/2025 | Date Form 4 was signed by Attorney-in-Fact for Stephen J. Hemsley. |
Recommendation
holdThis Form 4 filing reports a routine acquisition of shares by the CEO through dividend equivalents, which is a standard part of executive compensation and does not indicate a material change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this report.
Keywords
UnitedHealth Group, UNH, Stephen J. Hemsley, Insider Transaction, Form 4, Stock Ownership, Dividend Equivalents, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.